Incannex Healthcare Inc.
IXHL
$3.17
-$0.14-4.23%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -100.00% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -100.00% | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -100.00% | -- | -- |
| SG&A Expenses | 30.90% | 65.33% | -29.11% | -45.19% | -32.61% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 60.42% | 16.10% | 22.99% | -24.82% | -22.75% |
| Operating Income | -60.89% | -17.67% | -23.22% | 24.82% | 22.98% |
| Income Before Tax | -10.64% | -18.21% | -391.42% | 34.21% | -12.46% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.64% | -18.21% | -389.13% | 34.21% | -12.46% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.64% | -18.21% | -389.13% | 34.21% | -12.46% |
| EBIT | -60.89% | -17.67% | -23.22% | 24.82% | 22.98% |
| EBITDA | -64.56% | -17.85% | -23.86% | 25.63% | 25.21% |
| EPS Basic | 94.42% | 93.29% | -0.29% | 46.82% | -1.27% |
| Normalized Basic EPS | 94.42% | 93.28% | 0.76% | 60.13% | -1.26% |
| EPS Diluted | 94.42% | 93.29% | -0.29% | 46.82% | -1.27% |
| Normalized Diluted EPS | 94.42% | 93.28% | 0.76% | 60.13% | -1.26% |
| Average Basic Shares Outstanding | 1,882.77% | 1,658.85% | 387.74% | 23.68% | 11.03% |
| Average Diluted Shares Outstanding | 1,882.77% | 1,658.85% | 387.74% | 23.68% | 11.03% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |